Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
586
datasets available to search
ShareScore release 0.9.0
Dataset results
586 results for “allogeneic stem cell transplant”
Improvement of Women's Health After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT06279676. IPD Sharing: NO. Countries: 0. Publications: 0.
Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma
ClinicalTrials.gov study NCT03700450. IPD Sharing: NO. Countries: 1. Publications: 0.
CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT00038818. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML
ClinicalTrials.gov study NCT00606723. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression
ClinicalTrials.gov study NCT05126849. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Allogeneic Stem Cell Transplantation for Advanced Neuroblastoma Using MHC Mismatched Related Donors
ClinicalTrials.gov study NCT01462396. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT00079222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant
ClinicalTrials.gov study NCT00052598. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
ClinicalTrials.gov study NCT00674648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Infected Patients
ClinicalTrials.gov study NCT02732457. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transp
ClinicalTrials.gov study NCT07029958. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
ClinicalTrials.gov study NCT00959140. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT01596075. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Predicting Development of Diabetes Mellitus in Patients Undergoing Allogeneic Stem Cell Transplant
ClinicalTrials.gov study NCT02240381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leuke
ClinicalTrials.gov study NCT00875693. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06809699. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Therapy and Analytical Treatment Interruption in HIV+ Participants Who Received an Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT04720742. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06028828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
ClinicalTrials.gov study NCT01966367. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
ClinicalTrials.gov study NCT01666080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.